The whole hexapeptide repeats domain from avian PrP displays untypical hallmarks in aspect of the Cu2+ complexes formation  by Stańczak, Paweł et al.
FEBS Letters 581 (2007) 4544–4548The whole hexapeptide repeats domain from avian PrP displays
untypical hallmarks in aspect of the Cu2+ complexes formation
Paweł Stan´czaka, Paulina Juszczykb, Zbigniew Grzonkab, Henryk Kozłowskia,*
a Faculty of Chemistry, University of Wrocław, F. Joliot-Curie 14, 50-383 Wroclaw, Poland
b Faculty of Chemistry, University of Gdansk, Gdansk, Poland
Received 18 May 2007; revised 7 August 2007; accepted 8 August 2007
Available online 30 August 2007
Edited by Judit Ova´diAbstract Prions, the infectious agents responsible for the trans-
missible spongiform encephalopathies (TSEs) have deﬁed full
characterization for decades. Although the interactions of Cu2+
ions with PrP both in vivo and in vitro are well documented, there
are still a lot of ambiguities concerning the biological and chem-
ical nature of these eﬀects. In this work, we have investigated the
interactions of Cu2+ ions with whole repeat region of the copper-
binding domain (hexapeptide repeats) of chicken PrP. Our re-
sults provide explanations for the structural and chemical basis
of the speciﬁc interactions of Cu2+ ions with the hexapeptide re-
peat region. Furthermore, we show that SOD-like activity de-
pends on Cu2+ complexes.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Transmissible spongiform encephalopathies (TSE) are the
lethal neuropathological disorders that are related to many
symptoms like protein misfolding connected with deposition
of amyloid plaques and neuronal cell loss [1,2]. In these dis-
eases, the normal cellular form of prion protein (PrPC) under-
goes a conformational transformation to the pathological
infectious scrapie isoform PrPSc. In spite of unknown biologi-
cal role(s) of PrPC, it has been suggested that the protein is
implicated in: copper transport via endocytosis pathway from
extracellular space into the cell interior, copper buﬀering and
sensing, copper-reductase activity and neuronal superoxide
dismutase activity [3–12]. The precise understanding of the
copper binding sites in human PrPC is fundamental for under-
standing of the biological functioning of PrPC and the pro-
cesses related to neurodegeneration/neuroprotection. The
major research eﬀort was devoted to mammalian PrPs. The
other proteins derived from vertebrata such the ﬁshes, amphib-
ians, reptiles or birds were not much studied mostly due to the
lack of neurodegenerative disorders outside the class of Mam-
malia. The comparisons of the protein structures indicate that
the following architecture elements are preserved in all of the
proteins among vertebrata forming a scaﬀold that stabilizes*Corresponding author.
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doi:10.1016/j.febslet.2007.08.043the three dimensional structure of PrPC-type of protein: (i)
the arrangement of two long helices (a2 and a3) and their con-
nection by a disulﬁde bond, (ii) the packing of b-sheet across
these helices reinforced by a hydrogen bond network and
(iii) helix a1 located against the protein core [13]. Additionally
the N terminal region that is unstructured in the mammalian
PrPC is also ﬂexible in chicken protein and it seems to be
unstructured in turtle and frog PrPs as well. The hallmark of
the tandem repeat region of the chicken PrPC is the presence
of hexapeptide unit corresponding to human octapeptide re-
peat, though in the case of avian PrP there are in total seven
hexapeptide units: –(HNPGYP)5–QNPGYP–HNPGYP– [14].
Single hexapeptide unit binds copper ion in physiological pH
by {Nim,N
} donor set in the main trans/trans Xaa-Pro pep-
tide bond isomer as the involvement of the consecutive amide
nitrogens in metal ion chelation is disrupted by the presence of
Pro residue between Asn and Gly residues [15–17]. The charac-
teristic feature of the coordination mode of Cu2+ ion by multi-
repeat peptide units both for human and chicken proteins is
the formation of the multi-imidazole complexes within the
physiological pH region which may result in very eﬀective
SOD activity [18]. The interactions of Cu2+ ions with various
fragments of chicken hexapeptide repeat domain is relatively
well studied although nothing is known about binding ability
of the whole domain encompassing residues chPrP54-95. In
this work we have shown using potentiometric titrations and
the spectroscopic techniques (UV–Vis, CD and EPR) as well
as the semiempirical calculation (AM1/d) that the whole do-
main (chPrP54-95) behaves diﬀerently than its shorter frag-
ments described previously. Furthermore, the coordination
process via the whole hexapeptide domain shows unambigu-
ously the decrease of SOD activity of its Cu2+ complex when
compared to the tetrameric peptide fragment. This eﬀect could
be caused by the additional interactions of copper ion with
imidazole ligands at the apical positions protecting the en-
trance of superoxide substrate to the metal ion center.2. Materials and methods
2.1. Peptide synthesis and puriﬁcation
The peptide was synthesized according to published methods using
standard solid-phase synthesis techniques (Fmoc chemistry) with a
peptide synthesizer (Millipore 9050 Plus PepSynthesizer) [19,20].
Protected amino acids and other chemicals were purchased from
Peptide International, Fluka, and Sigma–Aldrich. The resin TentaGel
R RAM (Rapp Polymers; capacity of 0.18 mmol/g, 1 g) after auto-
matic synthesis and deprotection of the last N-Fmoc group, was
washed and treated with N-acetylimidazole for 24 h. The protected
peptide resin was washed with methanol and dried in vacuo. Then,blished by Elsevier B.V. All rights reserved.
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propylsilane (8.8/0.5/0.5/0.2, v/v)/1 g of resin at room temperature
for 2 h. After ﬁltration of the exhausted resin, the solvent was concen-
trated in vacuo and the residue was triturated with ether. The crude
peptide was puriﬁed by reversed-phase high-performance liquid chro-
matography (RP-HPLC) using a semipreparative Vydac C18 column
(10 · 250 mm, 5 lm) and Knauer chromatography system. The aque-
ous system consisted of 0.1% (v/v) TFA in water solution, while the or-
ganic phase was 80% acetonitrile in water, containing 0.08% (v/v)
TFA.
The elution was carried out by using a linear gradient from 10% to
50% organic phase in 120 min; the ﬂow rate was adjusted to 15 ml/min
and the separation was monitored by UV absorbancy at 223 nm.
The peptide-containing fractions were analyzed using the analytical
Kromasil C8 column (4.6 · 250 mm, 5 lm) on a Varian Vista 5500
chromatography system using a linear gradient 10–30% organic phase
in 20 min. The purity of the lyophilized 42-peptide was analyzed using
a linear gradient 0–100% organic phase in 60 min (UV detection at
223 nm) and by MALDI-TOF spectroscopy using a Brucker Biﬂex
III MALDI-TOF mass spectrometer (Brucker Daltonics). Anlytical
data were as follow: Ac–(HNPGYP)5QNPGYPHNPGYP–NH2,
Rf(HPLC) = 24.42 min; MS = 4711.5 [M
++1], calcd. 4711.0.
2.2. Potentiometric measurements
Stability constants for both proton and Cu2+ complexes were calcu-
lated from ﬁve titrations carried out over the pH range 3–11 at 298 K
using a total volume of 3 cm3. The purities and the exact concentration
of the ligands solution were determined by the method of Gran [21].
NaOH was added from a 0.500 cm3 micrometer syringe which was cal-
ibrated by both weight titration and the titration of standard materials.
Ligand concentration was 7 · 104 mol dm3. The metal to ligand mo-
lar ratio was 1:1. The pH-metric titrations were performed at 298 K in
(30:70 v/v) DMSO/water in 0.1 mol dm3 KNO3 on a MOLSPIN pH-
meter system using a normal Russel CMAW 711 semi-combined elec-
trode calibrated in proton concentrations using HNO3 dissolved in
(30:70 v/v) DMSO/water, respectively [22]. The calculated ionic prod-
uct for DMSO/water solutions was 14.519. The SUPERQUAD and
HYPERQUAD 2000 programs were used for the stability constant
calculations [23,24]. Standard deviations were computed by SUPER-
QUAD and HYPERQUAD 2000 and refer to random errors only.
They are, however, good indications of the importance of a particular
species in the equilibrium. The oligomeric species were also assumed in
the calculations, however for equimolar solutions there were rejected
as the minor species.
Comparisons of the pH-dependent stability constants are diﬃcult to
understand so to visualize the binding power of the particular peptides,
the hypothetical competition plot was used. Using overall stability con-
stants for particular metal-peptide systems the amount of bound cop-
per by each peptide was calculated.
2.2.1. EPR, UV–Vis and CD measurements. Solutions were of sim-
ilar concentrations to those used in the potentiometric studies and 30%
ethylene glycol was used as a cryoprotectant for EPR measurements.
Electron paramagnetic resonance (EPR) spectra were recorded on a
Bruker ESP 300 E spectrometer at X-band frequency (9.3 GHz) in li-
quid nitrogen. The EPR parameters were calculated for the spectra ob-
tained at the maximum concentration of the particular species for
which well-resolved separations were observed. The absorption spectra
were recorded on a Beckman DU 650 spectrophotometer. Circular
dichroism (CD) spectra were recorded on Jasco J 715 spectropolarim-
eter in the 750–240 nm range. The values of De (i.e. el  er) and e were
calculated at the maximum concentration of the particular species ob-
tained from the potentiometric data.
2.2.2. Determination of the superoxide dismutase activity. The
in vitro SOD activities of the copper complexes were evaluated at
298 K, in samples containing Cu(NO3)2 and peptides in the ratio 1:1
in Tris–HCl buﬀer (25 mM, pH 7.4 and pH 5.3, respectively). The
enzymatic activity was examined indirectly using nitroblue tetrazolium
(5 · 105 M) assay [25]. The superoxide anion was generated in situ by
the xanthine/xanthine oxidase reaction, and detected spectrophotomet-
rically by monitoring the reduction of NBT at 550 nm. The concentra-
tion of xanthine was 1 · 104 M, and the reaction was evoked by
adding appropriate amount of xanthin oxidase to form DA550 =
0.025–0.026 min1. The reduction rate of NBT was measured in the
presence as well as in the absence of the studied system ([Cu2+]-
tot = 0–1.5 · 106 M). The control experiment was carried out too, inthe presence of horseradish Cu, Zn-SOD (0–7 · 108 M). Separately,
there was carried out experiment in that the xanthine oxidase activity
was monitored following urate production, spectrophotometrically at
298 nm, in order to exclude any inhibition induced by the cop-
per(II)-peptide complexes. The SOD-like activity was then represented
as IC50 values indicating the concentration that causes 50% inhibition
of NBT reduction. The lower value of IC50 means higher SOD activity.3. Results and discussion
The whole domain of hexapeptide repeats – chPrP54-95
exhibits thirteen protonation constants, including those which
could be assigned to six imidazole nitrogens and seven pheno-
lic oxygens of Tyr residues. The calculated logK values of pro-
tonation constants of imidazole nitrogens vary from 4.97 up to
6.95 and for Tyr phenolic oxygens from 9.33 to 11.26 and they
agree with literature data found for the similar systems (Table
1) [15,17,26–28]. The calculations based on the pH titrations of
equimolar chPrP54-95 – Cu2+ solutions suggest the formation
of twelve mononuclear species (Fig. 1). Although, the number
of species is relatively high and they are partly overlapped, the
assignment of the spectroscopic data to the major complexes
was possible. The ﬁrst ﬁve species correspond to multi-imidaz-
ole complexes involving from two (CuH11L) up to possibly six
imidazole nitrogens (CuH7L). The ﬁrst major complex con-
ﬁrmed by the spectroscopic data is CuH9L involving four-
imidazole nitrogens. The d–d band at 601 nm and EPR param-
eters Ai = 189 G and gi = 2.235 conﬁrm such coordination
mode. The ‘‘physiological’’ species is very stable CuH7L com-
plex dominating in the pH range 6–8. The logK* = logb-
CuH7L  logbH7L = 9.02 distinctly diﬀers from that of four-
imidazole bound species (8.11 for chicken tetrameric peptide).
This higher logK* value may indicate the involvement of the
additional nitrogen donor(s) in the coordination of metal ion
[15]. The variations of the spectroscopic parameters, although
not very distinct, conﬁrm the additional imidazole nitrogen(s)
involvement,. There is a slight red-shift of the d–d band from
601 to 608 nm, and the changes in EPR parameters to
Ai = 199 G and gi = 2.231. The lack of the changes in the
CD spectra suggests that the apical coordination of copper
ion at ﬁfth and perhaps sixth imidazole nitrogen is rather
weak. The close relations between the spectroscopic parame-
ters and the coordination mode in the case of the weak apical
binding (contrary to the equatorial binding) are very diﬃcult
to follow due to the lowering of the complex symmetry in-
duced by axial binding.
It has been suggested that there is a strong correlation be-
tween the Cu2+ donor set and the SOD activity of the species
formed [18]. The most eﬀective for SOD activity is the four-
imidazole binding both with chicken and human repeat do-
main of PrP (IC50values 0.177 lM for chicken PrP peptide
and 0.175 lM for human PrP peptide at pH 7.4). The IC50
value of chPrP54-95 – Cu2+ complex in pH 7.4 is much higher
and it is equal to 0.489 lM, (IC50 of the native Cu, Zn-
SOD = 0.0044 lM and IC50 for simple salt Cu(NO3)2 Æ
6H2O = 0.980 lM). The very eﬀective SOD action besides
imidazole coordination is also dependent on geometry around
Cu2+ ion. The most eﬀective is the intermediate symmetry
between tetragonal and tetrahedral coordination to minimize
the Cu+/Cu2+ redox potential [29].
This result could also explain the data provided by Brown
et al. [5] indicating that Cu2+-chrPrPC possesses only 15% of
Table 1
Potentiometric and spectroscopic data for proton and Cu2+ complexes of Ac–(HNPGYP)5–QNPGYP–HNPGYP–NH2DMSO/H2O mixed solution.
Metal to ligand ratio = 1:1; [Cu2+] = 0.0007 M
Species logb logK UV–Vis CD EPR
k (nm) e (M1 cm1) k (nm) De (M1 cm1) Ai (G) gi
chPrP54-95
HL 11.26(1) logKTyr = 11.26
H2L 22.51(2) logKTyr = 11.25
H3L 33.06(2) logKTyr = 10.55
H4L 43.59(2) logKTyr = 10.53
H5L 53.82(1) logKTyr = 10.23
H6L 63.83(1) logKTyr = 10.01
H7L 73.16(1) logKTyr = 9.33
H8L 80.11(3) logKim = 6.95
H9L 86.43(2) logKim = 6.32
H10L 92.68(1) logKim = 6.25
H11L 98.25(1) logKim = 5.57
H12L 103.74(3) logKim = 5.49
H13L 108.71(5) logKim = 4.97
CuH11L 103.45(3) 4.90 Minor
CuH10L 99.02(2) 4.43 Minor
CuH9L 94.12(2) 4.90 601
a 92 759a 0.011 189 2.235
577a 0.049
277c 1.061
CuH8L 88.51(2) 5.61 Minor
CuH7L 82.18(2) 6.33 608




CuH6L 73.74(3) 8.44 Minor
CuH5L 64.56(3) 9.18 Minor
CuH4L 55.09(4) 9.47 Minor
CuH3L 44.61(7) 10.48 Minor
CuH2L 33.95(3) 10.66 Minor











bCharge transfer transition OTyr ! Cu2þ.
cCharge transfer transition Nimﬁ Cu2+.
dCharge transfer transition Nﬁ Cu2+.
eIntramolecular transition.
4546 P. Stan´czak et al. / FEBS Letters 581 (2007) 4544–4548the total Cu, Zn-SOD activity, while the mouse variant rPrPC
about 30% of SOD activity.
The four-imidazole binding occurs also for Cu2+-chPrP54-95
which dominates at pH 5.3. The IC50 value measured at pH 5.3
is really much lower than for pH 7.4 and it is equal to
0.227 lM. It is slightly higher than those values for four-imid-
azole complexes, e.g. with hPrPC due to lower concentration of
the four-imidazole species at pH studied for chPrP54-95 when
compared to hPrPC (Fig. 1) [18].
The deprotonation of CuH7L species results in the forma-
tion of CuH6L with presumably {3Nim,N
} donor sets. The
successive deprotonations down to CuL species with logK
varying from 9.18 to 10.66, are in agreement with deprotona-
tions of non-coordinating Tyr residues. Although the presence
of the charge transfer band at 417 nm could suggest some min-
or species involving one phenolic oxygen in the metal ion coor-
dination [15,30]. Increasing pH above 11 moves the d–dtransitions from 589 to 558 nm and it causes the strong change
of the CD and EPR parameters (Table 1) suggesting that in the
CuH2L complex additional amide nitrogen is involved result-
ing in the {2Nim,2N
} donor set [31]. The second amide nitro-
gen donor derives most likely from the Asn side chain amide
group as it was found in the shorter fragments of chPrP [15].
The di- and tri-nuclear species were also considered here.
However, our earlier performed experiments with mammalian
and chicken repeated regions proved that these oligonuclear
species if present are the minor complexes and could not be
determined by the methods used here.
To investigate the structural features of the whole hexapep-
tide domain from chicken PrP we have used the potentiometric
titrations to establish likely stoichiometry and the stability
constants of the Cu2+ complexes with PrP fragment. The spec-
troscopic data were used to evaluate the tentative coordination
modes. As it was previously shown [1,15,17], chicken repeated





































Fig. 1. Species distribution proﬁle for Cu2+ complexes of chPrP54-95
at 298 K and I = 0.1 M KNO3. [Cu
2+] = 7 · 104 M, metal to ligand
ratio 1:1.


























Fig. 3. Distribution proﬁles of competition between chPrP54-95 and
chPrP119-127 [34] in coordination of Cu2+. [Cu2+] = 7 · 104 M;
ligand (chPrP54-95) to metal to ligand (chPrP119-127) ratio 1:1:1.
P. Stan´czak et al. / FEBS Letters 581 (2007) 4544–4548 4547tetramer peptide is a less eﬀective ligand in coordination of
Cu2+ ions than the human tetrameric peptide fragment, how-
ever, the comparison of binding ability of the whole repetitive
domains clearly shows that the chicken analogue is slightly but
distinctly stronger chelator, because of the presence of addi-
tional His residues in the primary structure of chicken PrP
(Fig. 2). The data obtained for all PrP tandem repeat domains
clearly indicate that within the physiological pH range the imi-
dazoles of His residues are basic sites to bind Cu(II) ions by
prion proteins. The mode of binding strongly depends on the
number of His residues and their separation. The multi-imid-
azole binding by His-rich protein domains could be critical
for the biological activity of Cu(II)-protein systems.
The comparison of the binding ability of the ‘‘neurotoxic re-
gion’’ from chicken prion protein (residues encompassing 119-
127) and chPrP54-95, explicitly reveals that the domain of hex-
apeptide repeats binds copper ion much more eﬀectively than





























Fig. 2. Distribution proﬁles of competition between chPrP54-95 and
hPrP53-85 (Ac–(PHGGGWGQ)4–NH2) in coordination of Cu
2+.
[Cu2+] = 7 · 104 M; ligand (chPrP54-95) to metal to ligand (hPrP53-
85) ratio 1:1:1.Acknowledgement: This work was supported by Polish Ministry of
Education and Science (MEiN 1 T09A 008 30 and 1 T09A 149 30).References
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